Shared HLA‐E and Mamu‐E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF‐ and Fluorescence Polarisation‐Based Methods
European Journal of Immunology · 2026-01 · 56 (1)
DOI: 10.1002/eji.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 16.01.2026. Verfasst von Max N Quastel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Centre for Immuno-Oncology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, Peptides, Fluorescence Polarization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Wellcome Trust, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
The primary function of MHC‐E—human leukocyte antigen (HLA)‐E in humans and Mamu‐E in rhesus macaques—relates to immune surveillance via CD94/NKG2x receptors expressed on NK cells. However, a secondary role where MHC‐E presents immunogenic peptides to CD8 + T cells that provide protective immunity in specific settings has also been described. Given the high sequence homologies between HLA‐E and Mamu‐E molecules, peptide binding similarities are assumed but not systematically explored, with most studies prioritising HLA‐E. Here, we have optimised and developed two complementary techniques to explore the peptide repertoires of specific HLA‐E and Mamu‐E subtypes. We established a label‐free, high‐throughput nano‐differential scanning fluorimetry (nDSF)‐based method, where peptide binding strength is measured through thermal stability (T m ). This method revealed shared repertoires with occasional subtype‐specific peptide binding hierarchies for the MHC‐E types studied here, HLA‐E*01:03 and Mamu‐E*02:04. When combined with a fluorescence polarisation (FP) peptide competition assay, we show that half maximal inhibitory concentrations (IC 50 ) correlate exponentially with nDSF‐acquired T m data, revealing that modest T m increments equate to marked IC 50 differences, and hence substantial differences in relative peptide binding strengths. Collectively, these methodologies offer high‐throughput, scalable approaches to provide detailed peptide binding information for rhesus and human MHC‐E types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, Centre for Immuno-Oncology, University of Oxford, Oxford, UK.
- Institute For Life Sciences and Centre for Cancer Immunology, Faculty of Medicine, University of Southampton, Southampton, UK.
ORCID-Profile: Geraldine M Gillespie
Förderung
- The Wellcome Trust
- NIAID NIH HHS
- NIH HHS
- The Gates Foundation
- Wellcome Trust
- Bill and Melinda Gates Foundation
- National Institutes of Health
Zitieren
APA
Quastel, M. N., Ranawana, S. A., Peeters, B. W. A., van Hateren, A., McMichael, A. J., & Gillespie, G. M. (2026). Shared HLA‐E and Mamu‐E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF‐ and Fluorescence Polarisation‐Based Methods. European Journal of Immunology, 56(1). https://doi.org/10.1002/eji.70125
Vancouver
Quastel MN, Ranawana SA, Peeters BWA, van Hateren A, McMichael AJ, Gillespie GM. Shared HLA‐E and Mamu‐E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF‐ and Fluorescence Polarisation‐Based Methods. European Journal of Immunology. 2026;56(1). doi:10.1002/eji.70125
BibTeX
@article{Quastel2026,
author = {Quastel, Max N and Ranawana, Sashini A and Peeters, Bas W A and van Hateren, Andy and McMichael, Andrew J and Gillespie, Geraldine M},
title = {Shared HLA‐E and Mamu‐E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF‐ and Fluorescence Polarisation‐Based Methods},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {1},
doi = {10.1002/eji.70125}
}
EUVIMED